November 2013

Increased thromboses noted in patients with HeartMate II LVAD ()
Senate panel to discuss repealing SGR ()
Computerized probability tool lowers radiation exposure & costs ()
Researchers awarded 2013 Toshiba America Medical Systems/RSNA grants ()
Endurant II AAA Stent Graft from Medtronic delivers durable, consistent and proven outcomes in real-world setting ()
Preventing hospital readmissions may require broader strategy ()
Sex-specific chest pain traits may offer little diagnostic value ()
Magnetic ECG may detect lethal cardiac rhythm in utero ()
FDA removes restrictions on rosiglitazone ()
Bioprinting the heart: A no-brainer ()
FDA approves Promus Premier stent system ()
Fraud conviction lands cardiologist 78 months in prison ()
Xigduo (dapagliflozin and metformin hydrochloride) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes ()
Job outlook favors cardiovascular, MR techs ()
Structured weight reduction may reduce AF symptoms ()
More spending on PAD revascularizations doesn’t mean fewer amputations ()
CMS proposal allows rehab for chronic heart failure ()
U.S. TAVR outcomes match trial results ()
AHA: Evolocumab safe, effective at one year ()
CT combo may be as effective as invasive testing for CAD ()
Valiant 'Mona LSA' stent graft system from Medtronic demonstrates proof of concept in early feasibility study ()
Dr. Ziyad M. Hijazi appointed clinical chief for pediatrics at Sidra Medical and Research Center and chair of pediatrics at Weill Cornell Medical College in Qatar ()
Team of Chicago hospitals awarded grant to accelerate stroke research, treatments ()
Focusing the spotlight ()
FDA revises warning on 2 cardiac nuclear stress test drugs ()
Meta-analysis contradicts FDA’s findings on dabigatran ()
Demonstrating that ETC-1002 lowered LDL-C by an average of 32 percent and was well tolerated in patients with hypercholesterolemia and history of statin intolerance ()
MINERVA Trial at AHA meeting shows Medtronic pacemakers reduce the progression of permanent AF by 61 percent ()
URMC’s James A. DeWeese, M.D., helped shape cardiovascular surgery ()
Data indicate the antidote may be able to achieve immediate, complete and sustained reversal of dabigatran-induced anticoagulation in healthy humans ()
Singulex's assay for cardiovascular risk assessment highlighted in two presentations at AHA 2013 scientific sessions ()
Esaote showcases new prevention suite at EuroEcho 2013 ()
AHA slides: Rivaroxaban users more likely to stay on therapy ()
Little evidence to suggest statins adversely affect cognitive function ()
Devices may be safer than manual closure during PCI ()
AHA: Selective ablation saves nearly $3K per patient ()
AHA: MPI policy puts fiscal burden on practices ()
AHA: Genetics may not be useful in dosing warfarin ()
AHA: Edoxaban may be as effective & safer than warfarin ()
AHA, ACC defend guidelines, calculator ()
AHA: Varespladib raises heart attack risk in ACS patients ()
AHA: Dopamine, nesiritide don’t make dent in decongestion ()
Kentucky medical scientist wins AHA Achievement Award for “extraordinary contributions” to cardiovascular research ()
Pittsburgh scientist awarded American Heart Association prize for leadership of worldwide effort to clarify CVD risk in populations ()
Boston cardiologist given American Heart Association’s mentor award for guiding generations of future doctors, scientists ()
American Heart Association council honors Harvard investigator for discovery of new life-saving heart attack treatment ()
American Heart Association presents Clinical Research Prize to Florida neurologist for research on enhancing treatment for stroke ()
New York medical professor receives American Heart Association Chairman’s Award for volunteerism ()
Cincinnati researcher awarded American Heart Association prize for advancing knowledge of cardiovascular disease in children ()
AHA: Renal artery stenting proves futile in CORAL trial ()
AHA: Repair or replace for mitral regurgitation? It’s a tie ()
AHA: Lower-temp therapeutic hypothermia may not offer benefit ()
Report claims calculator overestimates risk ()
Healthcare access, cost worse in U.S. than peer countries ()
Panel outlines optimal use for IVUS, OCT & FFR ()
Third of NHLBI-funded trials never see timely publication ()
FDA places recall on Medtronic guidewires ()
Marquette General acquires largest cardiac physician group in region ()
Will guidelines quash drugs in the pipeline? ()
Warfarin beats out newer anticoagulants for value ()
CWRU team building an MRI-guided robotic heart catheter ()
Eleven local cardiologists to join John Muir Health’s medical foundation ()
World's largest imaging congress reveals latest techniques in heart failure ()
Detecting and treating silent heart disease: NewYork-Presbyterian Hospital and Weill Cornell Medical College launch new institute of cardiovascular imaging ()
Wireless sensors used to study meditation's effect on heart health ()
New center to deliver research-based solutions to rising health care costs ()
Murky projections ()
USPSTF mostly neutral on supplements in draft statement ()
Left ventriculography use varies across VA hospitals ()
Some hospital report cards don’t make the grade ()
First live Case with innovative transapical access technology at EACTS ()
AHA: 20 late-breaking trials, 19 special reports on docket ()
‘Fast Money’ statements get CEO in hot water ()
4 guidelines target cardiovascular disease prevention ()
Clear communication crucial to successful integration ()
Radioisotope ID’s high-risk, ruptured coronary plaques ()
Joint Commission names 1,099 hospitals top performers ()
ACE inhibitor/ARB combo risky in patients with diabetic nephropathy ()
Low infant weight increases risk of cardiac cath complications ()
Few poor metabolizers of clopidogrel have therapy intensified ()
Metformin may not offer cardiovascular benefits ()
Calcium-channel blocker/clarithromycin combo increases risk for AKI hospitalization ()
Affordable care puts cardiology, radiology in high demand ()
LIA software proven to detect lead failures more frequently than impedance alone on Riata, Durata and Endotak leads ()
Cardiac findings signal need to revise cancer trial reporting ()
Truly gee-whiz technology ()
Cyclotron deal expected to increase Rb-82 supply ()
Veniti receives CE Mark approval for Vici Venous Stent ()
FDA gives food industry 60 days to chew the fat ()
George Magovern, pioneering surgeon, dies at 89 ()
TAVR takes spotlight at TCT.13 ()
FDA recalls transseptal sheath kit ()
Electrophysiologist awarded $3.7M in bias lawsuit ()
Mortality rates higher in TAVR patients with severe mitral regurgitation ()
Neovasc Reducer achieves primary endpoint in Cosira trial, significantly improving functional capabilities in patients with refractory angina ()
Acusphere appoints Dr. William Ramage as chief development officer ()
Nurses scoop two top awards ()
Medtronic announces FDA approval to enroll first U.S. renal denervation clinical study for patients with moderate uncontrolled hypertension ()
Memorial and Heart Institute partner to advance cardiovascular care in East Texas ()
Vascular intervention: BIOTRONIK announces CE mark for PK Papyrus covered coronary stent for acute coronary artery perforation ()
AF ablation complications linked to low hospital, operator volume ()
Treating overall risk more effective at reining in heart disease ()
Study casts doubt on safety of testosterone therapy ()
Truven presents top 50 cardiovascular hospitals ()
AF an independent risk factor for first-time MI ()
Current practices help to lessen cardiac toxicity of radiotherapy ()
Third of CAD patients don't receive right combo of meds ()
Hands-free ultrasound device safe in patients with ischemic stroke ()
Boston Scientific buys Bard EP for $275M ()
Feds investigating ticagrelor’s pivotal trial ()
ACC Corner | CathPCI: ACC’s Flagship Registry Leads in Innovation ()
Duel Over Digoxin: Is It Safe for HF? ()
Going For-profit: Patient Outcomes Hold Steady ()
Vivid Valves: The Role of 3D Echo ()
North Kansas City Hospital: Technology & Teamwork Take CVIS Up a Notch ()
Emergency Care Partnerships: It Takes Two to Triage ()